Medline Inc.

Medline is a global healthcare company headquartered in Northfield, Illinois, that manufactures and distributes medical and surgical supplies, and provides supply chain solutions and clinical programs. Its mission is to provide quality medical products with superior value to healthcare providers and end-users, ultimately improving patient care and enhancing the quality of people's lives. The company also aims to make healthcare run better and create a sustainable future for the industry.

Medline offers an extensive portfolio of approximately 335,000 medical-surgical products, including advanced wound care, anesthesia, apparel, beds & mattresses, diagnostics, durable medical equipment (DME), gloves, incontinence, lab supplies, nursing supplies, and OR/surgery products. The company operates on a vertically integrated model, manufacturing over 190,000 of its own branded products while also distributing third-party items. Beyond products, Medline provides comprehensive services such as supply chain management, analytics, clinical education, and consulting. Its primary market is the business-to-business (B2B) healthcare sector, serving hospitals, extended care facilities, ambulatory surgery centers, physician offices, and home care agencies, with a supplementary business-to-consumer (B2C) presence through brands like Curad and "Medline at Home."

Medline completed its Initial Public Offering (IPO) on December 17, 2025, listing on the Nasdaq Stock Exchange under the ticker symbol MDLN. This IPO raised $6.26 billion, making it the largest IPO of the year. Jim Boyle has served as CEO since 2023, leading a team that includes Mike Drazin as CFO, Amanda Laabs as Chief Product Officer (effective January 1, 2025), and Steve Miller as COO (effective January 1, 2025). Medline is recognized as the healthcare industry's largest medical-surgical product manufacturer, supply chain provider, and clinical solutions partner, employing over 45,000 people worldwide and operating in more than 100 countries. In 2024, the company reported net sales of $25.5 billion, and as of April 28, 2026, its market capitalization stood at $37.4 billion.